甲状腺微小乳头状癌热消融诊疗指征专家共识

2019-08-30 中国医师协会超声医师分会 中华医学超声杂志(电子版).2019,16(8):571-574.

为进一步提高我国PTMC 的诊治水平,规范PTMC 热消融治疗方案,中国医师协会超声医师分会组织制定《甲状腺微小乳头状癌热消融诊疗指征专家共识》,结合我国PTMC 的诊治现状和实际情况,对PTMC 的诊断方法、热消融治疗的适应证和禁忌证达成了以下共识。

中文标题:

甲状腺微小乳头状癌热消融诊疗指征专家共识

发布日期:

2019-08-30

简要介绍:

为进一步提高我国PTMC 的诊治水平,规范PTMC 热消融治疗方案,中国医师协会超声医师分会组织制定《甲状腺微小乳头状癌热消融诊疗指征专家共识》,结合我国PTMC 的诊治现状和实际情况,对PTMC 的诊断方法、热消融治疗的适应证和禁忌证达成了以下共识。

 

拓展指南:甲状腺相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=甲状腺微小乳头状癌热消融诊疗指征专家共识)] GetToolGuiderByIdResponse(projectId=1, id=3514d1c0018103a0, title=甲状腺微小乳头状癌热消融诊疗指征专家共识, enTitle=, guiderFrom=中华医学超声杂志(电子版).2019,16(8):571-574., authorId=null, author=, summary=为进一步提高我国PTMC 的诊治水平,规范PTMC 热消融治疗方案,中国医师协会超声医师分会组织制定《甲状腺微小乳头状癌热消融诊疗指征专家共识》,结合我国PTMC 的诊治现状和实际情况,对PTMC 的诊断方法、热消融治疗的适应证和禁忌证达成了以下共识。 , cover=, journalId=null, articlesId=null, associationId=740, associationName=中国医师协会超声医师分会, associationIntro=中国医师协会超声医师分会是中国医师协会二级分会,是依法成立的我国超声医师行业组织。中国超声医师协会于2007年3月在北京成立。中国超声医师协会的成立,标志着我国在实现医师队伍专业化管理方面迈出了一大步,使我国全体超声执业医师将以整个行业的形式出现在社会活动中,参与人民的日常生活。中国超声医师协会代表着全国超声执业医师的切身利益,是我国超声医师管理、教育、自律、维权和认证的合法组织。, copyright=0, guiderPublishedTime=Fri Aug 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>为进一步提高我国PTMC 的诊治水平,规范PTMC 热消融治疗方案,中国医师协会超声医师分会组织制定《甲状腺微小乳头状癌热消融诊疗指征专家共识》,结合我国PTMC 的诊治现状和实际情况,对PTMC 的诊断方法、热消融治疗的适应证和禁忌证达成了以下共识。 </P> <P> </P>拓展指南:<strong>与<font color=red>甲状腺</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=d13ad1c001e9935a" title="2019 ESMO临床实践指南:甲状腺癌的诊断,治疗和随访" target=_blank>2019 ESMO临床实践指南:甲状腺癌的诊断,治疗和随访</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=96b171c001e976ed" title="NCCN临床实践指南:甲状腺癌(2019.V2)" target=_blank>NCCN临床实践指南:甲状腺癌(2019.V2)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f74381c001e9a492" title="妊娠和产后甲状腺疾病诊治指南(第2版)" target=_blank>妊娠和产后甲状腺疾病诊治指南(第2版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=081b31c001e901b7" title="2019 EANM实践指南:PET/CT检查甲状腺髓样癌" target=_blank>2019 EANM实践指南:PET/CT检查甲状腺髓样癌</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=53e351c001e683f2" title="碘难治性分化型甲状腺癌的诊治管理共识(2019年版)" target=_blank>碘难治性分化型甲状腺癌的诊治管理共识(2019年版)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%94%B2%E7%8A%B6%E8%85%BA" target=_blank>有关甲状腺更多指南</a></ul>, tagList=[TagDto(tagId=34214, tagName=甲状腺微小乳头状癌), TagDto(tagId=60214, tagName=热消融)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7840, appHits=392, showAppHits=5, pcHits=4293, showPcHits=4929, likes=104, shares=16, comments=9, approvalStatus=1, publishedTime=Wed Oct 30 00:01:51 CST 2019, publishedTimeString=2019-08-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Oct 30 00:01:51 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 17:45:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=甲状腺微小乳头状癌热消融诊疗指征专家共识)])
甲状腺微小乳头状癌热消融诊疗指征专家共识
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1240600, encodeId=60051240600ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f42f8290332, createdName=ms9000001506501155, createdTime=Tue Aug 23 22:08:01 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012339, encodeId=846a10123395b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5935587673, createdName=法师1, createdTime=Sat Aug 28 16:54:52 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012338, encodeId=2c6c10123384a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5935587673, createdName=法师1, createdTime=Sat Aug 28 16:54:35 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004914, encodeId=6c7b10049145c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Tue Aug 03 16:49:54 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003274, encodeId=729810032e48b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=ms3000000081494995, createdTime=Wed Jul 28 11:05:47 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2022-08-23 ms9000001506501155

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1240600, encodeId=60051240600ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f42f8290332, createdName=ms9000001506501155, createdTime=Tue Aug 23 22:08:01 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012339, encodeId=846a10123395b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5935587673, createdName=法师1, createdTime=Sat Aug 28 16:54:52 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012338, encodeId=2c6c10123384a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5935587673, createdName=法师1, createdTime=Sat Aug 28 16:54:35 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004914, encodeId=6c7b10049145c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Tue Aug 03 16:49:54 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003274, encodeId=729810032e48b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=ms3000000081494995, createdTime=Wed Jul 28 11:05:47 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-08-28 法师1

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1240600, encodeId=60051240600ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f42f8290332, createdName=ms9000001506501155, createdTime=Tue Aug 23 22:08:01 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012339, encodeId=846a10123395b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5935587673, createdName=法师1, createdTime=Sat Aug 28 16:54:52 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012338, encodeId=2c6c10123384a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5935587673, createdName=法师1, createdTime=Sat Aug 28 16:54:35 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004914, encodeId=6c7b10049145c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Tue Aug 03 16:49:54 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003274, encodeId=729810032e48b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=ms3000000081494995, createdTime=Wed Jul 28 11:05:47 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-08-28 法师1

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1240600, encodeId=60051240600ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f42f8290332, createdName=ms9000001506501155, createdTime=Tue Aug 23 22:08:01 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012339, encodeId=846a10123395b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5935587673, createdName=法师1, createdTime=Sat Aug 28 16:54:52 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012338, encodeId=2c6c10123384a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5935587673, createdName=法师1, createdTime=Sat Aug 28 16:54:35 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004914, encodeId=6c7b10049145c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Tue Aug 03 16:49:54 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003274, encodeId=729810032e48b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=ms3000000081494995, createdTime=Wed Jul 28 11:05:47 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-08-03 黄威龙

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1240600, encodeId=60051240600ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f42f8290332, createdName=ms9000001506501155, createdTime=Tue Aug 23 22:08:01 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012339, encodeId=846a10123395b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5935587673, createdName=法师1, createdTime=Sat Aug 28 16:54:52 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012338, encodeId=2c6c10123384a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5935587673, createdName=法师1, createdTime=Sat Aug 28 16:54:35 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004914, encodeId=6c7b10049145c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Tue Aug 03 16:49:54 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003274, encodeId=729810032e48b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=ms3000000081494995, createdTime=Wed Jul 28 11:05:47 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-07-28 ms3000000081494995

    学习

    0